VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer

HER2- Breast Cancer MORE >>

In an interview with Targeted Oncology, Mark Robson, MD, discussed the current and future role of olaparib, as well as the role of genetic testing in the treatment of breast cancer.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.